Cargando…
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2
OBJECTIVES: Neutralizing monoclonal antibodies (moAbs) improves clinical outcomes in patients with COVID-19 when administered during the initial days of infection. The action of moAbs may impair the generation or maintenance of effective immune memory, similar to that demonstrated in other viral dis...
Autores principales: | Rotundo, Salvatore, Vecchio, Eleonora, Abatino, Antonio, Giordano, Caterina, Mancuso, Serafina, Tassone, Maria Teresa, Costa, Chiara, Russo, Alessandro, Trecarichi, Enrico Maria, Cuda, Giovanni, Costanzo, Francesco Saverio, Palmieri, Camillo, Torti, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477616/ https://www.ncbi.nlm.nih.gov/pubmed/36116671 http://dx.doi.org/10.1016/j.ijid.2022.09.016 |
Ejemplares similares
-
Interleukin-6(2)/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies
por: Rotundo, Salvatore, et al.
Publicado: (2023) -
Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets
por: Russo, Alessandro, et al.
Publicado: (2022) -
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility
por: Biamonte, Flavia, et al.
Publicado: (2021) -
Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice
por: Marascio, Nadia, et al.
Publicado: (2022) -
Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation
por: Mazzitelli, Maria, et al.
Publicado: (2020)